| Literature DB >> 30439874 |
Donald R Hopkins, Ernesto Ruiz-Tiben, Adam J Weiss, Sharon L Roy, James Zingeser, Sarah Anne J Guagliardo.
Abstract
Dracunculiasis (Guinea worm disease), caused by the parasite Dracunculus medinensis, is acquired by drinking water containing copepods (water fleas) infected with its larvae. The worm typically emerges through the skin on a lower limb approximately 1 year after infection, causing pain and disability (1). The worldwide eradication campaign began at CDC in 1980. In 1986, the World Health Assembly called for dracunculiasis elimination, and the global Guinea Worm Eradication Program (GWEP), led by the Carter Center in partnership with the World Health Organization (WHO), United Nations Children's Fund (UNICEF), CDC, and others, began assisting ministries of health in countries with dracunculiasis. There is no vaccine or medicine to treat the disease; the GWEP relies on case containment* to prevent water contamination and other interventions to prevent infection, including health education, water filtration, chemical treatment of water, and provision of safe drinking water (1,2). In 1986, an estimated 3.5 million cases† occurred each year in 20§ African and Asian countries (3,4). This report, based on updated health ministry data (3), describes progress during January 2017-June 2018 and updates previous reports (1,4). In 2017, 30 cases were reported from Chad and Ethiopia, and 855 infected animals (mostly dogs) were reported from Chad, Ethiopia, and Mali, compared with 25 cases and 1,049 animal infections reported in 2016. During January-June 2018, the number of cases declined to three cases each in Chad and South Sudan and one in Angola, with 709 infected animals reported, compared with eight cases and 547 animal infections during the same period of 2017. With only five affected countries, the eradication goal is near, but is challenged by civil unrest, insecurity, and lingering epidemiologic and zoologic questions.Entities:
Mesh:
Year: 2018 PMID: 30439874 PMCID: PMC6290806 DOI: 10.15585/mmwr.mm6745a3
Source DB: PubMed Journal: MMWR Morb Mortal Wkly Rep ISSN: 0149-2195 Impact factor: 17.586
Number of reported indigenous dracunculiasis cases in humans,* by country — worldwide, January 2016–June 2018
| Country | No. of cases (% Contained) | % Change | No. of cases (% Contained) | % Change | ||
|---|---|---|---|---|---|---|
| Jan–Dec 2016 | Jan–Dec 2017 | Jan–Dec 2016 to Jan–Dec 2017 | Jan–Jun 2017 | Jan–Jun 2018 | Jan–Jun 2016 to Jan–Jun 2017 | |
| Chad | 16 (56) | 15 (60) | -6 | 8 (75) | 3 (100) | -63 |
| Ethiopia | 3 (67) | 15 (20) | 400 | 0 | 0 | 0 |
| Mali† | 0 | 0 | 0 | 0 | 0 | 0 |
| South Sudan | 6 (50) | 0 | -100 | 0 | 3 (0) | ∞ |
| Angola§ | 0 | 0 | 0 | 0 | 1 (0) | ∞ |
|
|
|
|
|
|
|
|
* No international importations were reported during the 18-month period January 2017–June 2018.
† Civil unrest and insecurity since a coup d'état in April 2012 continued to constrain program operations in regions with endemic dracunculiasis (Gao, Kidal, Mopti, and Timbuktu) during 2017–2018.
§ Final classification of case origin pending further investigation.
Number of reported indigenous dracunculiasis infections in animals,* by country — worldwide, January 2016–June 2018
| Country | No. of Cases (% Contained) | % Change | No. of Cases (% Contained) | % Change | ||
|---|---|---|---|---|---|---|
| Jan–Dec 2016 | Jan–Dec 2017 | Jan–Dec 2016 to Jan–Dec 2017 | Jan–Jun 2017 | Jan–Jun 2018 | Jan–Jun 2016 to Jan–Jun 2017 | |
| Chad | 1,022 (65) | 830 (75) | -19 | 535 (75) | 696 (78) | 30 |
| Ethiopia | 16 (63) | 15 (40) | -6 | 10 (30) | 10 (40) | 0 |
| Mali† | 11 (73) | 10 (80) | -9 | 2 (50) | 3 (67) | 0 |
|
|
|
| -18 |
|
|
|
* No international importations were reported during the 18-month period January 2017–June 2018.
† Civil unrest and insecurity since a coup d'état in April 2012 continued to constrain program operations in regions with endemic dracunculiasis (Gao, Kidal, Mopti, and Timbuktu) during 2017–2018.
Reported dracunculiasis cases in humans and animals, surveillance, and status of local interventions in villages with endemic disease, by country — worldwide, 2017
| Cases in humans/Surveillance/Intervention status | Country | Total | |||
|---|---|---|---|---|---|
| Chad* | Ethiopia | Mali† | South Sudan | ||
|
| |||||
| No. of indigenous cases, 2017 | 15 | 15 | 0 | 0 |
|
| No. of imported cases,§ 2017 | 0 | 0 | 0 | 0 |
|
| % Contained¶ in 2017 | 60 | 20 | 0 | 0 |
|
| % Change in indigenous cases in humans in villages or localities under surveillance, same period 2016 and 2017 | -6 | 400 | 0 | 0 |
|
|
| |||||
| No. of indigenous cases, 2017 | 830 | 15 | 10 | 0 |
|
| No. of imported cases,** 2017 | 0 | 0 | 5 | 0 |
|
| % Contained¶ in 2017 | 75 | 40 | 80 | 0 |
|
| % Change in indigenous cases in animals in villages or localities under surveillance, same period 2016 and 2017 | -19 | -6 | -9 | 0 |
|
|
| |||||
| No. of villages | 1,860 | 167 | 455 | 4,046 |
|
| % Reporting monthly | 99 | 98 | 99 | 99 |
|
| No. of villages reporting ≥1 cases in humans | 13 | 6 | 0 | 0 |
|
| No. of villages reporting only imported** cases in humans | 0 | 6 | 0 | 0 |
|
| No. of villages reporting indigenous cases in humans | 13 | 0 | 0 | 0 |
|
| No. of villages reporting ≥1 cases in animals | 271 | 6 | 10 | 0 |
|
| No. of villages reporting only imported** cases in animals | 0 | 0 | 5 | 0 |
|
| No. of villages reporting indigenous cases in animals | 271 | 6 | 5 | 0 |
|
|
| |||||
| No. of villages with endemic human dracunculiasis, 2016–2017 | 20 | 9 | 0 | 4 |
|
| % Reporting monthly†† | 100 | 100 | —§§ | 100 |
|
| % Filters in all households†† | 100 | 100 | —§§ | 100 |
|
| % Using temephos†† | 20 | 100 | —§§ | 100 |
|
| % ≥1 source of safe water†† | 80 | 89 | —§§ | 50 |
|
| % Provided health education†† | 100 | 100 | —§§ | 100 |
|
|
| |||||
| No. of villages with endemic animal dracunculiasis, 2016–2017 | 378 | 9 | 15 | 0 |
|
| % Reporting monthly†† | 100 | 100 | 100 | 0 |
|
| % Using temephos†† | 18 | 100 | 100 | 0 |
|
| % Provided health education†† | 100 | 100 | 100 | 0 |
|
* Participants at the annual Chad Guinea Worm Eradication Program review meeting in November 2014 adopted “1+ case village” as a new description for villages in Chad affected by cases of Guinea worm disease in humans or dogs infected with Guinea worms and defined it as “a village with one or more indigenous and/or imported cases of Guinea worm infections in humans, dogs, and/or cats in the current calendar year and/or previous year.”
† Civil unrest and insecurity since a coup d'état in April 2012 continued to constrain program operations in regions with endemic dracunculiasis (Gao, Kidal, Mopti, and Timbuktu) during 2017–2018.
§ Imported from another country.
¶ Transmission from a patient with dracunculiasis is contained only if all of the following conditions are met for each emerged worm: 1) the infected patient is identified ≤24 hours after worm emergence; 2) the patient has not entered any water source since the worm emerged; 3) a village volunteer or other healthcare provider has managed the patient properly, by cleaning and bandaging the lesion until the worm has been fully removed manually and by providing health education to discourage the patient from contaminating any water source (if two or more emerging worms are present, transmission is not contained until the last worm is removed); 4) the containment process, including verification of dracunculiasis, is validated by a Guinea Worm Eradication Program supervisor within 7 days of emergence of the worm; and 5) temephos is used to treat potentially contaminated surface water if any uncertainty about contamination of these sources of drinking water exists, or if a such a source of drinking water is known to have been contaminated.
** Imported from another in-country village with endemic disease.
†† The denominator is the number of villages or localities with endemic disease where the program applied interventions during 2016–2017.
§§ Data are not available.